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A computational systems approach identifies
synergistic specification genes that facilitate
lineage conversion to prostate tissue
Flaminia Talos1,2,3,4,w, Antonina Mitrofanova2,w, Sarah K. Bergren1,2,3,4, Andrea Califano2 & Michael M. Shen1,2,3,4
To date, reprogramming strategies for generating cell types of interest have been facilitated
by detailed understanding of relevant developmental regulatory factors. However, identifi-
cation of such regulatory drivers often represents a major challenge, as specific gene
combinations may be required for reprogramming. Here we show that a computational
systems approach can identify cell type specification genes (master regulators) that act
synergistically, and demonstrate its application for reprogramming of fibroblasts to prostate
tissue. We use three such master regulators (FOXA1, NKX3.1 and androgen receptor, AR) in
a primed conversion strategy starting from mouse fibroblasts, resulting in prostate tissue
grafts with appropriate histological and molecular properties that respond to androgen-
deprivation. Moreover, generation of reprogrammed prostate does not require traversal of
a pluripotent state. Thus, we describe a general strategy by which cell types and tissues can
be generated even with limited knowledge of the developmental pathways required for their
specification in vivo.
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M
any studies have demonstrated that expression of
lineage-specific regulatory genes can reprogram a
mature differentiated cell type into a distinct cell
type1,2. In many experimental paradigms, transdifferentiation
represents a direct conversion from one cell type to another3–9.
An alternative approach, known as ‘primed conversion’ or
‘indirect lineage conversion’, has used transient expression of
pluripotency factors to induce a plastic developmental state
permissive for respecification of desired cell fates10–12. In both
reprogramming strategies, however, the specific experimental
methods have depended upon prior detailed knowledge of the
developmental pathways and regulatory factors that specify the
desired cell type2,13. Consequently, if only limited information
regarding such pathways exist for the cell type of interest, the
identification of key regulatory drivers for reprogramming
represents a major challenge14. Furthermore, this challenge can
be particularly difficult when it is likely that combinations of
specific regulatory factors are required for reprogramming.
In the case of the prostate, the identification and analysis of
drivers of organogenesis is essential for understanding the
molecular basis of normal prostate specification, and ultimately
for generation of normal human prostate tissue for studies of
cancer initiation. However, relatively little is known about the key
transcriptional regulators of prostate specification and differen-
tiation in vivo15. Therefore, to identify such key regulatory
drivers, we have pursued an unbiased computational systems
approach that does not depend upon prior literature knowledge.
Our strategy is based on the recent generation of mouse and
human prostate interactomes (gene regulatory networks) and the
computational methodology employed to identify synergistic
drivers of prostate cancer malignancy16. In particular, the human
prostate interactome is highly relevant for normal prostate
biology, as it was generated using a large human patient data
set17 containing a substantial number of expression profiles from
normal/benign and low-grade tumour tissues. Furthermore, there
is significant cross-species conservation of transcriptional
regulatory programs between mouse and human prostate
interactomes16. Consequently, we anticipated that regulatory
genes for normal biological processes would be well-represented
in the human prostate interactome.
In our studies, we show that a computational systems approach
can identify cell type specification genes that act synergistically, and
demonstrate its application for reprogramming of fibroblasts to
prostate tissue. Using master regulator analysis18,19 to interrogate
the human prostate interactome, we have identified candidate
drivers of prostate specification. We have employed three such
master regulators (FOXA1, NKX3.1 and androgen receptor, AR) to
generate prostate tissue from mouse fibroblasts, using a primed
conversion strategy that involves expression of pluripotency factors,
tissue recombination with embryonic urogenital mesenchyme, and
renal grafting. Following growth in vivo, the resulting
reprogrammed prostate tissue displays appropriate expression of
prostate epithelial and stromal markers, can be serially grafted,
responds to androgen-deprivation and molecularly resembles
control prostate tissue. Interestingly, in contrast with primed
conversion of neurons and cardiomyocytes20,21, the generation of
reprogrammed prostate tissue does not appear to require passage
through a transient pluripotent state. Thus, our study describes a
general strategy by which cell types and tissues can be generated,
even with limited knowledge of the developmental pathways
required for their specification in vivo.
Results
Identification of candidate drivers of prostate organogenesis.
To identify transcriptional drivers (master regulators) of prostate
specification and differentiation, we used expression profiles from
different stages of prostate organogenesis22. Specifically, we
generated a prostate ‘organogenesis’ differential gene expression
signature corresponding to the transcriptome changes occurring
between the urogenital sinus at embryonic day 16.5, just prior to
initial prostatic budding, and the adult prostate at postnatal day
90. To identify candidate transcription factors that drive the
phenotypic transition between prostate anlage and mature
differentiated prostate tissue, we used the Master Regulator
Inference algorithm (MARINa)18,19 to interrogate the human
prostate interactome with the prostate organogenesis signature.
Candidate master regulators (MRs) were ranked based on their
differential transcriptional activity (DA), which was inferred by
the enrichment of their interactome targets in the organogenesis
signature (Fig. 1a; Supplementary Data 1).
Since efficient reprogramming is likely to be mediated by the
combined activity of multiple regulatory factors, we next used the
MARINa algorithm to identify MR pairs that are candidate
synergistic regulators of the prostate organogenesis signature.
As previously shown16,19, synergy between two MRs can be
computationally inferred by testing whether the enrichment of
their shared transcriptional targets in a signature of interest is
statistically more significant than enrichment of their individual
targets. This analysis identified 11 synergistic pairs, of
which 5 pairs contained activated candidate MRs with at least
1 MR differentially expressed in the organogenesis signature
(Fig. 1b); we focused on differentially expressed MRs since
experimental reprogramming would be most feasible if driven by
MR overexpression. Of these five MR pairs, the FOXA1/NKX3.1
pair was the most differentially expressed among all synergistic
pairs (Fig. 1c). Notably, these two genes have both been shown
to play important roles in prostate organogenesis23–25, but
their potential synergistic interaction during development
was not previously investigated. Interestingly, FOXA1 functions
as a pioneer transcription factor to recruit steroid hormone
receptors to chromatin26,27, and FOXA1 and NKX3.1 are
components of an enhancer complex together with AR on
a subset of AR targets28,29. Consequently, since AR was also
identified as a candidate prostate organogenesis MR, albeit at
a lower rank (Supplementary Data 1), we also investigated this
factor in our functional studies.
Reprogramming of fibroblasts to prostate tissue. Using the
candidate master regulators of prostate organogenesis, we
employed a primed conversion strategy to generate prostate tissue
from mouse embryonic fibroblasts (MEFs), which involves the
initial expression of the pluripotency factors OCT4, SOX2, KLF4
and c-MYC (OSKM) and culture conditions that promote
epithelial differentiation. Similar primed conversion approaches
have been used previously to produce cardiomyocytes, neuronal
progenitors and hepatocytes, with OSKM expression used to
destabilize the fibroblast differentiated state and lineage-specific
factors to specify the desired cell type10,11,30. In our strategy, we
expressed OSKM factors in MEFs under serum-free culture
conditions to generate cells with epithelial properties, followed
by lentiviral-mediated expression of FOXA1, NKX3.1 and/or
AR and renal grafting in combination with rat embryonic
urogenital sinus mesenchyme (UGM) to direct reprogrammed
cells towards prostate fate in vivo (Fig. 2a). As a starting
population, we used MEFs generated from embryonic day
13.5 dpc (E13.5) limb buds to exclude potential prostate
progenitors; in some experiments, we used MEFs from
limb buds of Nkx3.1lacZ/þ embryos25 to follow the expression
of the endogenous Nkx3.1 gene. For expression of the
OSKM pluripotency factors, we used two distinct approaches:
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(1) retroviral vectors expressing individual OSKM factors
constitutively (Supplementary Fig. 1a–d); or (2) mouse dermal
fibroblasts (MDFs) established from P0 neonates of R26R-rtTA;
Col1a1-tetO-OSKM mice, which contain a doxycycline-inducible
OSKM transgene31.
Following retroviral OSKM expression, we observed a rapid
morphological alteration in the infected fibroblasts by 48 h, at
which time the cells were placed in a serum-free defined basal
epithelial medium containing EGF, FGF and dexamethasone in
the absence of LIF. Over the course of 16 days, the cultures
became enriched for clusters of cells with a cuboidal morphology
and expressing epithelial markers, as shown by flow cytometry
for EpCAM and CD24 (Fig. 2b), and by immunostaining
for epithelial cytokeratins CK5 and CK8, as well as E-cadherin
and beta-catenin (Fig. 2c). Thus, we termed these cells
‘induced epithelial’ cells (iEpt cells). At 6 days after retroviral
OSKM expression, we infected the iEpt cells with lentiviruses
expressing FOXA1, NKX3.1 and/or AR singly or in combination
(Supplementary Fig. 1e–k). Notably, at 10 days following
lentiviral-mediated expression of candidate MRs, we found that
the iEptþMR cells showed a pronounced decrease in EpCAM
expression, particularly when expressing all three candidate
MRs (NKX3.1þARþ FOXA1¼NAF), whereas control
iEpt cells showed increased EpCAM expression by 16 days of
culture (Fig. 2b). At the same time, epithelial morphology and
marker expression were retained in the iEptþNAF cultures
(Fig. 2b,c). We observed similar formation of iEpt cells in the case
of the doxycycline-induced system, in which MDFs were
maintained in the presence of doxycycline to induce pluripotency
factor expression and basal epithelial media to stimulate
formation of iEpt cells.
Next, we performed tissue recombination of iEptþMR cells or
controls with rat embryonic UGM followed by renal grafting in
immunodeficient male nude mice, focusing on iEptþMR
cells generated using OSKM retroviruses. Such tissue recombina-
tion approaches have been used extensively to investigate prostate
formation as well as assays of prostate reconstitution32. In
the absence of iEpt or iEptþMR cells, UGM grafts alone
failed to grow, and lacked any epithelial ductal structures
(Fig. 2d; Table 1). As a positive control, we performed tissue
recombination and renal grafting using dissociated prostate
epithelial cells obtained from wild-type adult mice, together
with UGM (Fig. 2e,f; Table 1). We found that grafts of
iEpt cells lacking MR expression or grafts expressing a single
candidate MR could infrequently form small patches of prostate-
like tissue (Fig. 2g; Table 1). In contrast, grafts with pairs of
candidate MRs could generate prostate-like tissue with high
efficiency, although subtle distinctions in histology were apparent
in prostate-like tissues obtained from different iEptþMR






















































Figure 1 | Identification of driver genes for prostate specification. (a) List of activated candidate master regulators (MRs) and enrichment profile of their
activated (red bars) and repressed (blue bars) target genes on the prostate organogenesis signature, as defined by differential expression analysis of
embryonic day 16.5 (E16.5) and postnatal day 90 (P90). Differential activity (DA) is computed as the Normalized Enrichment Score (NES) of the
transcriptional targets of a given MR among differentially expressed genes in the signature as computed by MARINa, while differential expression
(DE) corresponds to the change in expression of a given MR in the signature. Red indicates increased differential activity/expression, white indicates no
significant activity/expression and grey indicates that the gene was not represented on the experimental platform used to generate the signature.
(b) MR pairs that are predicted to act synergistically regulate the prostate organogenesis signature, including t-test and synergy P values. (c) Network
representation of both shared and individual transcriptional targets of NKX3.1 and FOXA1; under-expressed genes and over-expressed genes are
represented as blue and red circles, respectively.
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combination of all three candidate MRs in iEptþNAF grafts
efficiently generated prostate tissue that were phenotypically
indistinguishable from those found in control grafts (Fig. 2j,k;
Table 1). Furthermore, the iEptþNAF combination was the
only one that could form large homogeneous regions of prostate
tissue (Fig. 2j).
To characterize prostate differentiation within the tissue grafts,
we performed immunostaining with a range of markers using
control and iEptþMR grafts, focusing on the iEptþNAF grafts,
which contained all three candidate MRs. Immunostaining for
the luminal markers CK8 and CK18 and the basal markers
CK5 and p63 showed that the distribution of basal and luminal
iEpt + NAFiEpt + NAFiEpt + NAiEpt + NA
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cells was similar between control and iEptþNAF grafts (n¼ 6 for
each marker; Fig. 3a–d). Immunostaining for synaptophysin
also showed that rare neuroendocrine cells could be detected in
both control and iEptþNAF grafts (n¼ 2; Fig. 3e,f). Importantly,
we could readily detect expression of the secretory protein
Probasin in both control and iEptþNAF grafts, indicating
the presence of functional differentiated prostate epithelium
(n¼ 9 grafts; Fig. 3g,h).
Moreover, examination of cytokeratin markers and Probasin
expression in tissue grafts generated by iEpt cells as well as other
iEptþMR combinations also revealed results consistent
with histological analyses. We found that only 1 out of 18 grafts
of iEpt cells lacking MR expression contained a small patch of
prostate-like tissue, as defined by its ductal structure and
expression of Probasin (Fig. 4a–f; Table 1). Grafts of iEpt cells
that expressed either Nkx3.1 or Foxa1 as a single candidate
MR could only form glandular structures that did not resemble
prostate tissue, whereas grafts of iEpt cells expressing AR alone
could sometimes generate small patches of prostate-like tissue
with limited regions of Probasin immunoreactivity (Fig. 4g–r;
Table 1). However, grafts of iEpt cells expressing pairs
of candidate MRs (Nkx3.1 and Foxa1, or Nkx3.1 and AR)
successfully generated prostate-like tissue with Probasin expres-
sion (Fig. 4s–x; Table 1). Similar results were obtained with grafts
analysed from doxycycline-inducible iEpt cells expressing Foxa1
and AR (n¼ 2) (Fig. 4y-a0). Notably, grafts of pluripotent iPSC in
the presence (n¼ 14) or absence (n¼ 2) of UGM only generated
teratomas that lacked prostate tissue (Fig. 4b0–d0). In addition,
the MRs were unable to mediate direct conversion of MEFs
to prostate tissue in the absence of OSKM factors, as we did
not observe epithelial phenotypes in culture or formation of
prostate tissue in vivo in renal grafts (Table 1).
Based on our findings that combinations of prostate organo-
genesis MRs, but not single genes, were successful in the
reprogramming assay, we assessed whether the experimentally
observed effects of the MRs were synergistic, as had been
predicted computationally. For this purpose, we compared the
observed combined effects of the MRs to their predicted ‘additive’
effects using a log-linear model (Supplementary Table 1). This
analysis demonstrated a significant synergy of the experimentally
observed effects over the predicted additive effects (P values
ranging from 0.020 to 0.0023 using a one-sample t-test),
indicating that the prostate organogenesis MRs act synergistically
in the reprogramming assay.
Reprogrammed prostate tissue is fully differentiated. To assess
whether the reprogrammed prostate tissue displays the properties
of fully differentiated prostate tissue in vivo, we performed
additional marker analyses, assessed its response to androgen-
deprivation, and investigated its similarity to native prostate
at the molecular level. In particular, we could detect strong
nuclear expression of AR, Nkx3.1, and Foxa1 in iEptþNAF
grafts (n¼ 9 for each marker), consistent with their fully differ-
entiated state (Fig. 3i–n). Moreover, we observed
that expression of the stromal markers smooth muscle a-actin
(SMA) and vimentin was normal in the iEptþNAF grafts
(n¼ 3; Fig. 3o,p), indicating that stromal differentiation in the
tissue recombinants was properly stimulated by interactions
with the prostate epithelium, as is known for wild-type tissue
recombinants33. Finally, in experiments using MEFs established
from Nkx3.1lacZ/þ mice, we found that beta-galactosidase
staining confirmed the origin of the ductal tissue from the
MEFs, as well as activation of the endogenous Nkx3.1 locus
(Fig. 3q,r).
After tissue dissociation and recombination with embryonic
urogenital mesenchyme, reprogrammed prostate tissue could
generate secondary renal grafts containing prostate tissue
(Fig. 3s), consistent with the presence of stem/progenitor cells
within the primary graft. Using such secondary grafts, we
examined whether reprogrammed prostate tissue would respond
to androgen-deprivation, which leads to tissue regression
associated with massive apoptosis of luminal epithelial cells.
Whereas hormonally intact iEptþNAF secondary grafts (n¼ 2)
displayed strong nuclear AR immunostaining, iEptþNAF
secondary grafts in mice that were castrated and analysed
1 month later (n¼ 3) showed cytoplasmic AR expression
(Fig. 3t,u). Furthermore, cellular proliferation as indicated
by Ki67 immunoreactivity was readily detected in the intact
iEptþNAF grafts (10.1±1.9% Ki67-positive epithelial cells,
n¼ 2 grafts), but was abolished in the regressed iEptþNAF
grafts (1.1±0.7% Ki67 positive, n¼ 3 grafts; P¼ 0.001 by paired
t-test with two-tailed distribution; Fig. 3v,w). In contrast,
apoptosis was essentially undetectable by TUNEL staining of
intact iEptþNAF grafts (0.2±0.2% TUNEL-positive epithelial
cells, n¼ 2 grafts), but was readily detected at 3 days after
castration (2.2±0.3%, n¼ 2 grafts; P¼ 0.01 by paired t-test with
two-tailed distribution) and was less evident in the fully regressed
iEptþNAF graft at 1 month after castration (1.1±0.2%, n¼ 2
grafts; Fig. 3x–z).
To examine the molecular features of the reprogrammed
prostate tissue, we performed RNA-seq analyses of MEFs (n¼ 6),
wild-type prostate tissue from 6-week-old C57BL/6 mice (n¼ 6),
iEpt only tissue recombinants (n¼ 2), and iEptþNAF recombi-
nants (n¼ 5), with prostate content of the tissue recombinants
confirmed by histology and immunostaining (Fig. 5a–f). Using
these RNA-seq data, we determined whether the iEptþNAF
grafts retain expression of the exogenous virally introduced
human OSKM as well as organogenesis MRs by comparison of
the exogenous human coding regions and the endogenous mouse
untranslated regions (UTRs) and coding regions (Supplementary
Table 2). These data suggest that maintenance of reprogrammed
prostate tissue does not require continuous expression of
exogenous MRs.
To assess the molecular similarity of the reprogrammed
prostate tissue to normal wild-type mouse prostate tissue,
Figure 2 | Conversion of fibroblasts into prostate tissue. (a) Strategy for production of prostate tissue from fibroblasts by primed conversion.
(b) Generation of EpCAMþCD24þ cells in MEFs transduced with retroviruses expressing OCT4, SOX2, KLF4, and c-MYC is decreased by infection at
6 d with the indicated combinations of prostate MRs (Nkx3.1þAR¼NA; Nkx3.1þ Foxa1¼NF; Nkx3.1þARþ Foxa1¼NAF), as analysed by flow-sorting at
16 days. Representative data from four independent experiments are shown. (c) Immunostaining for the mesenchymal marker vimentin (Vim) decreases
and for the epithelial markers b-catenin (b-cat), E-cadherin (Ecad), cytokeratin 5 (CK5), and cytokeratin 8 (CK8) increases after formation of iEpt cells and
infection with MRs (iEptþNAF); scale bars indicate 50mm. Representative images from four independent experiments are shown. (d–k) Hematoxylin–
eosin (H&E) staining of renal grafts obtained from tissue recombination assays with rat embryonic urogenital mesenchyme (UGM); scale bars indicate
100mm. (d) Renal graft performed using UGM alone lacks glandular tissue structures (n¼ 5 grafts); adjoining kidney tissue is indicated. (e,f) Dissociated
mouse prostate cells generate prostate tissue in renal grafts (n¼4). (g), iEpt cells expressing Nkx3.1 (iEptþN) generate glandular tissue that does not
resemble prostate (n¼ 3). (h,i), iEpt cells expressing Nkx3.1 and AR (iEptþNA) generate prostate-like tissue (n¼6). (j,k), iEpt cells infected with Nkx3.1,
AR, and Foxa1 (iEptþNAF) generate prostate-like tissue that resembles control grafts (n¼ 18).
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we performed Gene Set Enrichment Analysis (GSEA) using
a reprogrammed tissue recombinant gene expression signature,
defined between profiles of iEptþNAF grafts versus MEFs,
and a normal prostate signature, defined between profiles of
wild-type prostate tissue versus MEFs. Comparison of these
signatures revealed striking enrichment between the repro-
grammed tissue recombinant signature and the normal prostate
signature (Fig. 5g). As a further comparison, we performed
a second GSEA using a second reprogrammed prostate signature
defined between profiles of iEptþNAF grafts versus iEpt grafts
(that did not contain prostate tissue), compared with a normal
prostate signature defined between wild-type prostate tissue
versus iEpt grafts. Again, we found a strong enrichment between
these two signatures (Fig. 5h), indicating the significant molecular
similarity of the reprogrammed tissue to normal prostate.
Reprogramming does not require traversal of pluripotency.
Recent studies have reported that the generation of neuronal
progenitors and cardiomyocytes using primed conversion
protocols that utilize expression of OSKM require an inter-
mediate ‘pluripotent’ state marked by transient expression of
Nanog and Oct4 (refs 20,21). To investigate whether iEpt and
iEptþMR cells traverse this intermediate state, we used MEFs
and MDFs derived from Oct4-GFP knock-in mice34. Using
retroviral expression of OSKM, we could not detect any
GFP-positive cells in iEpt culture, even though we could readily
detect GFP-positive iPSC colonies grown in ES culture media
(Supplementary Fig. 2a,b). We obtained similar results using
MEFs derived from a transgenic Tg(Oct4-GFP) reporter line35
(Supplementary Fig. 2c).
As a more stringent test, we employed lineage-tracing to
follow the expression of Tomato in MEFs derived from
Tg(Nanog-CreERT2); R26R-Tomato mice that we have generated
(Supplementary Fig. 3a,b). When cultured in the presence of
4-hydroxytamoxifen (4-OHT), activation of Nanog transgene
expression results in Cre-mediated recombination and expression
of the Tomato reporter, which permanently marks
Nanog-positive cells and all of their progeny, even if they no
longer express Nanog, thus enabling detection of transient Nanog
expression. Thus, under standard conditions for generation of
iPSC cells, we readily detected Tomato-positive cells that
subsequently gave rise to Tomato-positive iPSC colonies
(Supplementary Fig. 3c,d). Under iEpt conditions, however, we
found that Tomato-positive cells did not represent a significant
percentage of the culture at any time point examined, and
that their frequency was decreased by the expression of
MRs (Fig. 6a,b; Supplementary Fig. 3e). We obtained similar
findings using MEFs from Nanog-CreER/þ ; R26R-Tomato/þ
mice20 as well as Oct4CreER/þ ; R26R-YFP mice36 that were
previously utilized for lineage-tracing during neuronal and
cardiomyocyte primed conversion (Supplementary Fig. 3f,g).
Notably, following tissue recombination and renal grafting of
Tg(Nanog-CreERT2); R26R-Tomato iEpt cells cultured in the
continuous presence of 4-OHT, Tomato-positive cells were
only found as scattered populations (Fig. 6c). After grafting
of Tg(Nanog-CreERT2); R26R-Tomato iEptþNAF cells grown
with continuous 4-OHT both in culture and in vivo, we
found that Tomato-positive cells formed ductal structures
that did not display prostate features, whereas Probasin-positive
prostate ducts were uniformly Tomato-negative (Fig. 6d–f).
Thus, these results indicate that primed conversion does
not necessarily require transit through an intermediate
Nanog-positive state.
Discussion
Our findings show that Nkx3.1, AR, and Foxa1, which we
identified computationally as candidate master regulators of
prostate organogenesis are in combination sufficient to confer
prostate identity upon fibroblasts. Taken together with previous
loss-of-function analyses of these genes23–25,37,38, we demonstrate
that these genes are both necessary and sufficient for prostate
specification, and validate their identification as master regulators
of prostate organogenesis. Our results are also consistent with
the observation that Nkx3.1 and Foxa1 interact with AR to form
a complex on a subset of AR transcriptional targets28,29, although
they are likely to have AR-independent functions as well.
In addition, recent work has shown that overexpression of
Nkx3.1 can respecify mouse seminal vesicle epithelium to
prostate39, indicating that the reprogramming activity of
Nkx3.1 is a more general property. Overall, our results confirm
the predicted synergy of these factors in prostate reprogramming,
providing experimental validation of the computational
approaches used in master regulator analysis in a gain-of-
function assay.
Our findings also highlight the value of tissue recombination
approaches for the generation of reprogrammed tissues contain-
ing epithelial and stromal compartments. In particular, the ability
of organ-specific mesenchyme to promote expansion of epithelial
tissue progenitors has been previously recognized40. Furthermore,
earlier studies have described the generation of prostate
tissue from human embryonic stem (ES) cells in tissue
recombination and renal grafting assays with embryonic
urogenital mesenchyme or seminal vesicle mesenchyme41;
however, we were unable to detect formation of prostate tissue
Table 1 | Summary of renal grafting assays.
Grafts (þUGM) Performed Grown Prostate tissue P value
UGM only 5 0 0
MEFs 5 0 0
MEFsþNkx3.1þARþ Foxa1 10 0 0
iEpt 22 18 1 (5.6%)
iEptþNkx3.1 8 3 0
iEptþ Foxa1 4 4 0
iEptþAR 10 9 3 (33%) 0.093
iEptþNkx3.1þ Foxa1 13 10 4 (40%) 0.041
iEptþNkx3.1þAR 21 13 6 (46%) 0.026
iEptþNkx3.1þARþ Foxa1 56 46 18 (39%) 0.013
AR, androgen receptor; iEpt, induced epithelial cells; MEFs, mouse embryonic fibroblasts; UGM, urogenital mesenchyme.
Shown is the likelihood of the indicated graft combination to produce any prostate-like tissue compared to iEpt cells alone. P value is calculated by two-tailed Fisher’s exact test. Note that the iEptþAR
grafts contained only small patches of prostate-like tissue with Probasin immunoreactivity, whereas only the three-factor NAF combination could generate large homogeneous regions of prostate tissue.
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Figure 3 | Reprogrammed tissue is similar to control prostate tissue. (a–x) Immunofluorescence analyses of control grafts and reprogrammed
iEptþNAF grafts; Scale bar, 50mm. (a–d) Luminal cells are positive for CK18 and CK8, whereas basal cells (arrowheads) are positive for CK5 and
p63 (n¼6 grafts). (e,f) Detection of rare synaptophysin (Syn)-positive neuroendocrine cells (arrows; n¼ 2). (g,h) Expression of the prostate-specific
secretory protein Probasin (n¼9). (i–n) Expression of AR, Nkx3.1 and Foxa1 (n¼9 for each marker). (o,p) Formation of differentiated stroma expressing
smooth muscle actin (SMA) and vimentin (n¼ 3). (q) Expression of beta-galactosidase in epithelial cells of control prostate graft (n¼ 1) generated from
dissociated prostate epithelial cells from Nkx3.1lacZ/þ mice. (r) Expression of beta-galactosidase in prostate epithelium of a graft (n¼ 6) generated from
iEptþNAF cells derived from Nkx3.1lacZ/þ MEFs, demonstrating the donor origin of the epithelial cells as well as expression of the endogenous Nkx3.1
locus. (s–z) Secondary grafts of reprogrammed prostate tissue. (s) Expression of the luminal marker CK18 and the basal marker p63 (arrowheads) (n¼ 3).
(t,u) Nuclear localization of AR in the hormonally intact state (n¼ 2) (t) versus cytoplasmic localization at 1 month after castration (n¼ 3) (u).
(v,w) Immunostaining for the proliferation marker Ki67 in intact (n¼ 2) (v) and 1 month regressed grafts (n¼ 3) (w). (x–z) TUNEL staining to visualize
apoptotic cells in an intact graft (n¼ 2) (x) and at 3 days (n¼ 2) (y) and 1 month after castration (n¼ 2) (z).
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following grafting of mouse iPSC with UGM. More recently,
reprogrammed thymic epithelial cells recombined with immature
thymocytes and embryonic thymic mesenchyme have been
shown to produce functional T cells in renal grafts42.
Taken together, our studies establish proof-of-concept for
a new systems-driven approach for the unbiased and unsuper-
vised identification of specification factors that can drive tissue
reprogramming. In contrast with methods that reprogram
fibroblasts to a specific cell type in culture, our approach
facilitates generation of entire three-dimensional functional
tissues in vivo. Recent studies have described several distinct
computational methods for the prediction of candidate cell type
specification genes43–45. Notably, given the general requirement
for multiple factors to implement reprogramming, the proposed
approach for identification of synergistic interactions is especially
advantageous, since it reduces the relatively large number of
potential specification genes to a handful of computationally
prioritized combinations that can be more easily validated
experimentally. Indeed, synergy analysis has been highly
successful in identifying gene combinations that drive B-cell
proliferation, the mesenchymal subtype of glioblastoma, and
prostate cancer malignancy16,18,19. Our new findings suggest that
it will be generally successful for elucidation of reprogramming
factor combinations. Thus, we propose that these and related
computational systems approaches will be effective in filling
current gaps in our understanding of regulatory factors governing
differentiation of desired cell types and tissues.
Methods
Computational systems analyses. We generated the prostate organogenesis
signature from published microarray expression data22. This signature is
represented by a list of genes ranked by their differential expression between
E16.5 and P90 (n¼ 3 biological replicates each). The organogenesis signature was
used to interrogate a human prostate interactome16 for master regulator analysis
and computational prediction of synergy18,19. We performed 1,000 gene
permutations to estimate statistical significance (P value) of the Normalized
Enrichment Score (NES) for identified MRs. The NES of each MR protein
represents the enrichment of its interactome transcriptional targets among genes
differentially expressed in the organogenesis signature. Master regulator analysis
(MARINa) is available for download at http://califano.c2b2.columbia.edu/software/
as well as through the viper package46 in Bioconductor.
Mouse strains. All experiments involving animals were performed according to
protocols approved by the Institutional Animal Care and Use Committee at
Columbia University Medical Center. Nkx3.1lacZ/þ mice have been previously
described25, while other lines were obtained from the Jackson Laboratory
Induced Mutant Resource, corresponding to Gt(ROSA)26Sortm1(rtTA*M2)Jae
Col1a1tm4(tetO-Pou5f1,-Sox2,-Klf4,-Myc)Jae/J, stock #011011)31, Oct4-GFP
(B6:129S4-Pou5f1tm2Jae/J, stock #008214)34, Tg(Oct4-GFP) (B6;CBA-Tg(Pou5f1-
EGFP)2Mnn/J, stock #004654)35, Oct4-CreER (B6(SJL)-Pou5f1tm1.1(cre/Esr1*)Yseg/J,
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Figure 4 | Analyses of grafts containing two or fewer candidate master regulators. (a–c) Typical non-prostatic glandular histology in grafts of iEpt cells
with rat urogenital mesenchyme (UGM), showing absence of basal-luminal organization (n¼ 17) (b) and lack of Probasin-positive secretions (n¼ 5) (c).
(d–f) Small prostate-like region found in 1 of 18 iEpt grafts that is Probasin-positive (f). (g–i) Non-prostatic histology of graft generated by iEpt cells infected
with Nkx3.1 alone (iEptþN) (n¼ 3). (j–l), Non-prostatic histology of graft generated by iEpt cells infected with Foxa1 alone (iEptþ F) (n¼4). (m–r) Most
grafts generated by iEpt cells infected with AR displayed typical non-prostatic histology (n¼6) (m–o) but 3 out of 9 grafts contained small prostate-like
regions with positive Probasin immunoreactivity (p–r). (s–u) Prostate-like region in graft generated by iEpt cells expressing Nkx3.1 and Foxa1 (iEptþNF)
(n¼4). (v–x) Prostate-like region in graft generated by iEpt cells expressing Nkx3.1 and AR (iEptþNA) (n¼ 6). (y-a0) Prostate tissue generated from
iEpt cells expressing AR and Foxa1 (iEptþAF) from mouse dermal fibroblasts (MDFs) at passage 1, which were derived from mice engineered with
a doxycycline-inducible OSKM cassette (n¼ 2). (b0–d0), Teratoma produced by graft of induced pluripotent stem cells (iPSC) together with rat UGM, with
glandular regions that lack Probasin expression (n¼4) (d0). Scale bar, 100mm (in panels depicting hematoxylin–eosin staining); 50mm (in panels showing
immunofluorescence).
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stock #007908), and R26R-YFP (B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J, stock
#006148)47.
To generate Tg(Nanog-CreERT2) mice, BAC recombineering48 was used to
insert a CreERT2 cassette precisely at the translation initiation site of the
Nanog locus on the bacterial artificial chromosome (BAC) vector RP23-406B15
(BACPAC Resources), which has been previously shown to contain essential
Nanog regulatory sequences49. The resulting engineered BAC was utilized for
pronuclear microinjection to generate transgenic mice, using standard methods.
Cell culture. MEFs were derived from the limbs of E13.5 embryos and dermal
fibroblasts (MDFs) were derived from P0-P1 mice using standard protocols. Male
and female littermates were pooled to generate fibroblast cultures. We sorted these
MEF and MDF cultures against CD45/Ter119/CD31/Mac-1(CD11b)/EpCAM
to exclude potential contamination with hematopoietic, endothelial, macrophages
and epithelial cells.
MEFs and MDFs were cultured in DMEM supplemented with 10% FBS,
1 antibiotic/antimycotic (Invitrogen) on 0.1% gelatin-coated tissue culture plates
(Millipore). iEpt cells were generated in defined basal epithelial media Cnt-Prime
(CellnTec) supplemented with 100 nM dexamethasone (Sigma). iPSCs were
maintained in DMEM/F12 medium supplemented with 10% knock-out serum
replacement, 1x nonessential amino acids, 1 GlutaMax, 1 antibiotic/
antimycotic, 55mM b-mercaptoethanol (all from Invitrogen), and 1000 U ml 1
mouse Leukemia Inhibitory Factor (LIF; Millipore). iPSC colonies were passaged
on mitomycin-treated passage 1 wild-type MEFs and maintained in the same
media with 10% FBS. Mitomycin was used at a concentration of 10 mg ml 1
for 3 h.
Reprogramming assays. For studies using OSKM expression from the Rebna
retroviral vector50, viral constructs51 encoding human OCT4, SOX2, KLF4 and
c-MYC were transfected into Phoenix E cells using Lipofectamine 2000
(Invitrogen), either as a pool or individually in equal concentrations, in which
case viral supernatants were mixed just prior to use. After 24 h, transfected
Phoenix E cells were treated with 2 mg ml 1 puromycin for 2 days and then
switched to MEF media. After 12 h in MEF media, viral supernatants were collected
every 12 h until cultures became overgrown, followed by splitting 1:4 and another
round of puromycin selection. LinCD11bEpCam MEFs or MDFs were
plated at 250,000 cells per plate in 6 cm dishes and infected with 45-mm-filtered
viral supernatants 4 every 12 h. Cells were switched to basal epithelial medium
at 48 h after the last infection. At 6 days post-OSKM infection, cells were infected
4 over 2 days with lentiviruses expressing mouse Nkx3.1-IRES-GFP, human
AR and mouse Foxa1 individually or in combination; lentiviral supernatants
were generated as above. The resulting iEptþMR cells were cultured for an
additional 8 days in basal epithelial medium to allow flow-sorting for Nkx3.1-
GFPþ cells, puromycin selection for Foxa1þ cells and blasticidin selection for
ARþ cells. OSKM-expressing cells that were not infected with lentiviral MRs
were used as controls.
For studies using doxycycline-inducible OSKM, passage 0 MDFs obtained
from P0 Col1a1-tetO-OKSM;R26r-rtTA*M2 mice were treated with 2 mg ml 1
doxycycline in MEF media for 9 days followed by 8 days of doxycycline withdrawal
in basal epithelial media to generate iEpt cells. To generate iEptþMR cells,
lentiviral Nkx3.1, AR and Foxa1 pools (singly or in combination) were used to
transduce the cells during days 6 and 7 of doxycycline-induction.
To generate iPSC cells as controls, we used Rebna OSKM retroviruses to infect
MEFs derived from E13.5 Oct4-GFP embryos and from E13.5 Tg(Nanog-CreERT2);
R26R-Tomato embryos, followed by culture in iPSC media in the presence
of LIF. Stable undifferentiated GFP-positive or Tomato-positive iPSC
colonies were picked at 14–21 days after infection and expanded on feeder
cells (mitomycin-treated MEFs) in the presence of LIF. To generate iPSC
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Figure 5 | Reprogrammed prostate tissue is similar to native prostate at the molecular level. (a–f) Representative regions of prostate tissue in
iEptþNAF grafts used for RNA-seq and GSEA analyses; scale bars correspond to 50mm. (g) GSEA comparing signature of reprogrammed prostate tissue
defined between iEptþNAF grafts (n¼ 5) and fibroblasts (n¼ 6) with signature of normal prostate defined between wild-type prostate tissue (n¼6) and
fibroblasts. (h) GSEA comparing signature of reprogrammed prostate tissue defined between iEptþNAF grafts (n¼ 5) and iEpt grafts (n¼ 2) with
signature of normal prostate defined between wild-type prostate tissue (n¼ 6) and iEpt grafts.
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Figure 6 | Conversion to prostate does not require an intermediate pluripotent state. (a) Direct visualization of Tomato-positive cells obtained by
retroviral expression of OSKM in Tg(Nanog-CreERT2); R26R-Tomato MEFs, followed by culture in basal epithelial media and 4-OHT (1 mM) for the indicated
times; Scale bar, 100mm. Representative images are shown from three independent experiments. (b) Detection of Tomato-positive cells by flow-sorting of
Tg(Nanog-CreERT2); R26R-Tomato MEFs, iEpt cells cultured in the continual presence of 4-OHT, or iEpt cells infected with lentiviruses for the indicated
MRs at 6 days post-infection with OSKM and analysed at day 13 of continuous culture with 4-OHT. Detection of GFP is due to expression of the
Nkx3.1-IRES-GFP construct used for MR expression. Representative data are shown from 3 independent experiments. (c) Direct visualization of
Tomato-positive cells in renal grafts (n¼ 3) generated from Tg(Nanog-CreERT2); R26R-Tomato iEpt cells cultured continuously in the presence of 4-OHT.
(d–f) Tomato-positive cells in grafts (n¼ 3) generated from Tg(Nanog-CreERT2); R26R-Tomato iEptþNAF cells; 4-OHT was continuously administered to
cells in culture as well as to host graft recipients. Scale bar, 50mm. (d) GFP-positive cells (expressing Nkx3.1) contribute to prostate-like tissue which is
distinct from regions containing Tomato-positive cells; Scale bar, 50mm. (e) Tomato-positive regions do not form recognizable prostate-like ductal
structures. (f) Probasin-positive ducts are Tomato-negative.
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Col1a1-tetO-OKSM;R26r-rtTA*M2 mice for 11 days with 2 mg ml 1 doxycycline in
iPSC media in the presence of LIF, followed by doxycycline withdrawal for 5 days.
Doxycycline-independent iPSC colonies were picked and passaged onto feeder cells
for several passages and used in tissue recombination assays.
Tissue recombination and renal grafting assays. To perform tissue recombi-
nation, 25,000–50,000 iEpt or iEptþMR cells at 16 days post-infection with OSKM
or 1,000–1,500 iPSC cells were mixed with 250,000 dissociated rat urogenital
mesenchyme (UGM) cells from E18.5 Sprague-Dawley rat embryos (Charles River),
and resuspended in 10ml of 9:1 collagen/setting buffer solution (10 Earle’s
balanced salt solution (Life Technologies), 0.2 M NaHCO3, 50 mM NaOH).
Recombinants were cultured overnight in DMEM with 10% FBS and 100 nM
DHT, followed by grafting under the kidney capsules of male nude mice
(Taconic CrTac:NCr-Foxn1nu/nu). For each tissue recombination experiment, rat
UGM alone was grafted as a negative control to exclude contamination with rat
urogenital epithelium. To augment androgen levels, 12.5 mg per 90 day release
testosterone pellets (Innovative Research of America) were placed subcutaneously
into graft hosts. Renal grafts were harvested for analysis at 6 weeks after implantation.
For control tissue recombinants, mouse prostates (all lobes combined) from WT
C57BL/6 and Nkx3.1lacZ/þ mice at 6 weeks of age were collected and dissociated
following published protocols52, followed by tissue recombination as above. A similar
procedure was employed to generate secondary grafts by dissociation of primary
iEptþMR grafts followed by tissue recombination with rat UGM and renal graft
implantation. Finally, to evaluate the effect of androgen deprivation on the prostate
tissue obtained in renal grafts, nude mouse hosts containing iEptþMRs secondary
grafts were castrated and the testosterone pellet removed.
Analysis of grafts by histology and immunostaining. Cells cultured in chamber
slides were fixed with 4% paraformaldehyde for 30 min, followed by PBS washes and
permeabilization-blocking in 0.05% Tween 20/1 PBS/5% goat serum. For paraffin
sectioning, tissues were fixed in 10% formalin for 12–24 h, followed by tissue
processing and embedding. Hematoxylin–eosin staining was performed using stan-
dard procedures. 5mm sections were subjected to antigen retrieval by boiling in
citrate acid-based antigen unmasking solution (Vector Labs) for 20 min. Sections or
fixed cells were incubated with primary antibodies (see antibody
suppliers and dilutions in Supplementary Table 3) at 4 C overnight in humidified
chambers. Alexa Fluors (Life Technologies) were used for secondary antibodies.
Fluorescence images were acquired using a Leica TCS5 spectral confocal microscope.
Tissue recombinants were systematically sectioned through the entire graft,
with four to six 5 mm sections collected every 40–150 mm depending on the graft
size, and used for hematoxylin–eosin staining. When prostate-like glandular
morphology was observed by bright-field microscopy, we collected 30 serial 5-mm
sections for hematoxylin–eosin and immunostaining. Grafts that were entirely
composed of prostate tissue were sectioned throughout, with four 5-mm sections
collected every 30mm.
We defined prostate tissue histologically as stratified ductal epithelium
forming irregular lumenal projections together with eosinophilic secretions and
surrounded by stroma. Tissue architecture was evaluated by immunostaining with
basal (CK5) and luminal (CK8) epithelial markers, and confirmed as functional
prostate tissue by immunostaining with Probasin, a prostate-specific secretory
protein. Immunostaining for beta-galactosidase was used to demonstrate activation
of endogenous prostate-specific Nkx3.1 expression in grafts derived from
Nkx3.1lacZ/þ iEptþMR cells.
Analysis of experimental synergy. To determine whether the observed effects of
the master regulators (MRs) were synergistic, we compared their experimentally
observed combined effects in the reprogramming assay to their predicted ‘additive’
effects. The predicted additive effects for Nkx3.1, Foxa1, and AR were estimated
using a log-linear model based upon observed efficiencies of prostate tissue
formation in the reprogramming assay (expressed as %, ranging from 0 to 100%).
Log-transformed efficiencies were utilized to fit a linear least-squares curve between
control (iEpt) and each test (for example, iEptþMR) group. Slopes for either
(i) a combination of single MRs, or (ii) a pair of MRs combined with an effect of a
single MR, were then added to estimate their potential additive effect over the base.
The predicted additive effect was then compared to the experimentally observed
effect using a one-sample (one-tailed) t-test.
Molecular analysis of gene expression profiles. RNA-sequencing analyses
(30 million single-end reads) for MEFs (n¼ 6), iEptþNAF grafts (n¼ 5), iEpt only
grafts (n¼ 2), and wild-type prostate tissue (n¼ 6) were performed by the
Columbia Genome Center using an Illumina Hi-Seq instrument. Computational
analyses were done in R-studio 0.99.902, R v3.3.0. Raw counts were normalized
using the DESeq package53. Differential gene expression signatures were
defined using t-test statistics between graft and fibroblast or iEpt samples to
define the reprogrammed tissue signature, and between prostate and fibroblast or
iEpt samples to define the normal prostate signature. Signatures were compared
using GSEA54, where the statistical significance (P value) of the enrichment was
estimated using 1000 gene permutations.
To determine the expression of exogenous MRs and pluripotency factors in
grafts, we performed alignment of the untranslated regions (UTRs) and coding
regions of the respective genes to the RNA-seq BAM files of our samples using
SAMtools. The UTRs and the coding regions were input according to the UCSC
Genome Browser using the human GRCh37/hg19 and the mouse NCBI Build
37/mm9 genome data as references. The presence of exogenous and endogenous
transcripts was confirmed by visualization with the Integrative Genomics Viewer
(IGV).
Data availability. The RNA-seq data generated in this study are deposited in the
Gene Expression Omnibus database under the accession code GSE83298. The
authors declare that all the data supporting the findings of this study are available
within this article and its Supplementary Information, or are available from the
corresponding author upon reasonable request.
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